Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial
Eli Lilly and Company
Tamara S Hannon; Lily C Chao; Margarita Barrientos-Pérez; Karthik Chandrasekhar Pamidipati; Laura Fernández Landó; Clare J Lee; Hiren Patel; Brandon K Bergman